Get to the heart of the most recent advances in lipid management and cardiovascular disease with Lipid Luminations, which features scientific and clinical research updates, novel emerging treatment options, and best practices in patient care.
Alan S. Brown, MD, FACC, FAHA, FNLA
Treating Erectile Dysfunction: Key Cardiovascular Considerations
Pharmacometabolomics to Predict Statin Response: Ready for Prime Time?
Triglyceride-Lowering Therapies: Addressing Gaps in the Guidelines
PCSK9 Antibodies for Dyslipidemia: Efficacy, Safety, and Non-Lipid Effects
Canadian Perspectives on Managing Lipid Disorders in Children
Lipid-Lowering Drug Interactions in Cardiovascular Agents
Lipidologists Confronting the Obesity Epidemic: Perspectives from NLA President Joyce Ross
Lipidologists Confronting the Obesity Epidemic: Perspectives from NLA Preside...
Big Data in Lipids: Refining Cardiovascular Risk Profiles Nationwide
Joyce Ross, MSN, CRNP, CS, CLS, FNLA, FPCNA
Cardiovascular Risk Reduction in the Elderly: Best Lipid Strategies
What's the Deal with Saturated Fat and Cardiovascular Disease Risk?
Lipidology's Advances and Growing Pains: Technologies, Drug Trials, and Guidelines
Lipidology's Advances and Growing Pains: Technologies, Drug Trials, and Guide...
Harold Bays, MD, FNLA
The Lipidology Essentials: Making of a Specialty's Annual Summary
Patrice L Basanta-Henry, MD, MHSc, FACOG
Recognition and Management of Mental Illness for the Non-Psychiatric Clinician
Special Populations in Patient-Centered Management of Dyslipidemia
Keith C. Ferdinand, MD
Updated NLA Recommendations for African American Patients
Dyslipidemia in The Elderly: How Old is "Too Old" to Treat?